Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Aardvark Therapeutics, Inc. (AARD) had Return on Equity of -6.18% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-9.31M |
|
-- |
|
-- |
|
$10.47M |
|
$-10.47M |
|
$1.16M |
|
$-9.31M |
|
$-9.29M |
|
$-9.31M |
|
$-9.31M |
|
$-9.31M |
|
$-9.29M |
|
$-10.47M |
|
$-10.55M |
|
13.19M |
|
13.19M |
|
$-0.71 |
|
$-0.71 |
|
| Balance Sheet Financials | |
$154.55M |
|
-- |
|
$2.47M |
|
$157.03M |
|
$5.98M |
|
-- |
|
$0.36M |
|
$6.34M |
|
$150.69M |
|
$150.69M |
|
$150.69M |
|
21.69M |
|
| Cash Flow Statement Financials | |
$-11.39M |
|
$-112.62M |
|
$88.88M |
|
$61.64M |
|
$26.50M |
|
$-35.14M |
|
$0.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
25.86 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-11.39M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-6.18% |
-6.18% |
|
-5.93% |
|
-6.18% |
|
$6.95 |
|
$-0.86 |
|
$-0.86 |
|